A young man presented with a large liver mass and positive hepatitis B virus markers. This 18-year-old male has developed ascites, jaundice, high serum alpha fetoprotein (AFP) level, liver mass and portal hypertension, without fever or calcification in the mass. All favored the diagnosis of rapidly, progressive hepatocellular carcinoma, however proven hepatoblastoma in liver biopsy. Hepatoblastoma usually manifests prior to the third year of life, but can rarely be seen in older children or adults. Although HCC rarely can be presented in young patients with HBV infection, but in patients without cirrhosis hepatoblastoma should be considered as the first possible diagnosis.
INTRODUCTION
Hepatoblastoma is a primary malignant liver tumor that originates from embryonic and fetal liver cells. It constitutes 30%-45% of all primary liver tumors and 50%-60% of all malignant tumors that occur during childhood. 1, 2 Hepatoblastoma is often associated with a congenital anomaly, particularly with familial adenomatous polyposis coli. 3 It is primarily a tumor of young children, and more than 90% of tumors usually present before five years old, but rarely presents in older children or adults. 4, 5 Males are affected twice as often as females. However with increasing age, the gender difference equalizes. This is a relatively rapid growing tumor. The serum alfa-fetoprotein (AFP) levels are markedly elevated in approximately 90% of the patients. The tumor can be diagnosed by ultrasonography, CT scan or MRI. Calcifications are frequently visualized. 6 
CASE REPORT
An 18-year-old man referred due to right upper quadrant (RUQ) pain since two months prior to admission in this hospital. The RUQ pain, which was constant has had radiation to his back, and gradually was worsened. He gradually developed yellowish discoloration of the sclera and skin and abdominal distention. He had complaints of low back pain, that aggravated by movement since one month prior to admission. The patient had anorexia with a 15 kg weight loss during these two months with no history of fever, chills, vomiting, diarrhea, change in bowel habits or tarry stools.
In physical examination he was icteric and wasted. The abdomen was protruded, flanks were bulged and shifting dullness was positive. Few collateral vessels were present in abdominal surface. The liver was enlarged with firm two nodular consistency, and spleen was palpable by ballottement maneuver. Examination of genitalia and testes were normal. Laboratory results were as follows: hemoglobin (9.1 g/dl), platelets (257000/mm 3 Ultrasonography of abdomen showed a coarse liver parenchyma, without mass or space occupying lesion. The portal vein diameter was 11 mm. The spleen was 201x55 mm with a homogeneous echo pattern. Moderate ascites was also noted.
Endoscopy was notable for the presence of F1 esophageal varices, and fundal varices (without active bleeding or stigmata of recent hemorrhage), and a kissing type duodenal ulcer disease.
Color Doppler Ultrasonography of abdomen showed splenic and portal vein thrombosis, but the hepatic artery and inferior vena cava were normal. The initial serum alpha-fetoprotein level was 300 ng/ml (normal 0-8.5) that after ten days increased to 112000 ng/ml. Spiral triphasic CT scan ( Fig. 1) and MRI ( Fig. 2 ) revealed atrophic right lobe with mild enlargement of left lobe.
The caudate lobe was heterogeneous and severely enlarged. There was thrombosis in the main portal vein with extension to the intra-hepatic branches, and splenic vein. Moderate ascites was also seen. The patient underwent a liver biopsy under sonography guide.
Liver biopsy (Figs. 3 and 4) contained normal as well as neoplastic tissues. In the non-neoplastic tissues, there was no evidence of cirrhosis. The tumor component was composed of small and large nests of small hepatocyte-like cells. The nests were separated by very delicate fibrovascular fascicles. The individual cells were round to polygonal shaped with amphophilic to somewhat eosinophilic cytoplasm and round to oval hyperchromatic nuclei with occasional nucleoli. Intranuclear optically clear inclusions were occasionally seen. Intracytoplasmic micro-as well as macro-vesicular fat accumulation was prominent. There were also scattered and large aggregates of polygonal cells with abundant fat accumulation in the cytoplasm (Fig.  3) . Immunohistochemistry (IHC) was positive for Hepar1 (focal), vimentin, CK, AFP, pCEA and AFP (diffuse), and alfa-1 anti-trypsin. IHC was negative for CD34, synaptophysin, NSE, TTF-1, desmin, chromogranin, placental alkaline phosphatase, CD99, CD10, albumin, and S100. According to the histopathology features and IHC profile, the diagnosis was reported as fetal type hepatoblastoma.
DISCUSSION
Hepatoblastoma is the most common primary liver tumor of childhood and adolescence, but is rarely found in adults, this tumor presents more commonly before the age of three years, predominantly in males. [7] [8] [9] However with increasing age the gender difference disappears and the incidence becomes equal among genders. Hepatoblastoma commonly forms a large mass within the right lobe of the liver. 6 Multiple nodules in both lobes are also a common presentation. Less common is the diffuse tumor that involves the entire liver. 4 In children, hepatoblastoma can be presented with rapidly enlarging upper abdominal mass, weight loss, and or failure to thrive; in adults symptoms of abdominal pain, fever, malaise and the presence of an abdominal mass are more frequent. 10 Paraneoplastic syndrome with unusual finding, such as virilization also can be seen. The serum marker AFP is mostly elevated in this tumor. 11 Initial diagnostic evaluations for liver structural abnormalities are based on imaging studies. Ultrasonography is a noninvasive modality useful in the evaluation of liver mass. Hepatoblastoma presents as a hyperechoic, solid, intrahepatic mass on ultrasound. 12 Other standard investigations include CT and MRI. Calcification is seen in tumors detected by CT scan. 13 Hepatocellular carcinoma is the most common primary liver tumor seen in adults and is closely related to cirrhosis and chronic liver disease, particularly in patients with chronic hepatitis B virus infection. Patients with hepatocellular carcinoma remain asymptomatic for a long period of time. Diagnosis of hepatocellular carcinoma should be considered in patients with cirrhosis who deteriorate clinically or has a liver mass in radiological workups.
14 In any patient with cirrhosis and newly developed signs of decompensation such as ascites, hepatic encephalopathy, variceal bleeding or fever of unknown origin, the presence of hepatocellular carcinoma should be investigated. 15 Our patient presented with ascites, esophageal varices and a large firm liver and positive hepatitis B virus antigen, so the initial clinical impression was HBV induced liver cirrhosis with hepatocellular carcinoma, but normal platelet count, and albumin was not in favor of advanced portal hypertension.
Hepatocellular carcinoma is the first diagnosis in any patient with clinical findings of cirrhosis, liver mass and elevated serum AFP. HCC have been reported in HBV infected non-cirrhotic young patients below age 20 but is a rare finding. In a report by Sezaki et al. only four out of 187 patients with HCC were young with ages; 10, 22, 23, and 26 years. They suggested predisposition to HCC due to integration of HBV genome into host genome during intrauterine life. 16 Although development of portal vein thrombosis in a patient with cirrhosis can be explained, however the presence of both cirrhosis and hepatocellular carcinoma in a young adult with isolated HBV infection is very unusual. In young patients with liver mass (es), without evidence of cirrhosis and an elevated AFP, hepatoblastoma should be considered.
The impression of caudate lobe hypertrophy in the radiologic reports can cause confusion in such cases for differentiation between cirrhosis plus hepatocellular carcinoma versus a large slowly growing hepatoblastoma arising from caudate lobe within non cirrhotic liver. Any pathology that causes caudate lobe enlargement can induce pressure effect on the portal venous system. This process can induce right and left lobe liver atrophy and portal vein thrombosis also. However for final diagnosis, liver biopsy was performed, which confirmed large hepatoblastoma. Pathologic diagnosis of adult hepatoblastoma is difficult in that hepatic teratoma; carcinosarcoma, malignant mesenchymal tumor, and hepatocellular with sarcomatous changes and hepatoblastomatous lesions should also be considered and be differentiated by appropriate immunohistochemistry evaluation. Treatment of choice is complete surgical resection, and without surgery the survival is poor. However improvements in survival have occurred with standardized chemotherapy that reduces the tumor size, enabling complete tumor excision. This process can be performed in patients who present with unresectable or metastatic disease. 17 Chemotherapy reduces bleeding from the tumor and surrounding normal parenchyma and vascular structures, therefore facilitating resection of lesion. Chemotherapy has been proven effective as both an adjuvant and neoadjuvant treatment for tumor shrinkage, followed by surgical removal of the mass. Hepatoblastoma is sensitive to chemotherapeutic drugs such as doxorubicin, cisplatin, vincristine, 5-FU, and cyclophosphamide. 18 This presentation of hepatoblastoma in a young patient with positive hepatitis B virus infection and portal hypertension (ascites, esophageal varices, and splenomegaly) is unusual. However the normal platelet count and serum albumin in the patient is not in favor of advanced cirrhosis as the cause of portal hypertension. The histologic evaluation of non-tumoral segments of liver can help us for differentiation of cirrhosis with HCC or a non-HCC liver tumor arising in a non-cirrhotic liver. Calcification within the mass, which is in favor of hepatoblastoma, was not shown in abdominal triphasic CT scan; and only the liver biopsy results were positive for hepatoblastoma. The patient expired one month after diagnosis because his family rejected treatment.
